These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33090239)

  • 61. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome].
    Hernández-Ramos I; Parra-Esquivel P; López-Hernández Á; Burillo-Putze G
    An Sist Sanit Navar; 2019 Aug; 42(2):227-230. PubMed ID: 31133765
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cannabinoid hyperemesis syndrome.
    Valdivielso Cortázar E; Ucha Abal P; Alonso Aguirre P
    Rev Esp Enferm Dig; 2018 May; 110(5):334-335. PubMed ID: 29745720
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease.
    Woods JA; Wright NJ; Gee J; Scobey MW
    Am J Ther; 2016; 23(2):e601-5. PubMed ID: 24413371
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?
    Richards JR
    Med Hypotheses; 2017 Jun; 103():90-95. PubMed ID: 28571820
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
    Desjardins N; Jamoulle O; Taddeo D; Stheneur C
    J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting.
    Ruffle JK; Bajgoric S; Samra K; Chandrapalan S; Aziz Q; Farmer AD
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1403-8. PubMed ID: 26445382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Cannabinoid hyperemesis syndrome should be considered by recurrent vomiting].
    Nordholm-Carstensen A
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cannabinoid hyperemesis: marijuana puts patients in hot water.
    Wallace D; Martin AL; Park B
    Australas Psychiatry; 2007 Apr; 15(2):156-8. PubMed ID: 17464661
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Marijuana Use: Early Recognition for a Cannabinoid Hyperemesis Syndrome.
    Abrams T; Gantioque R
    Adv Emerg Nurs J; 2020; 42(1):30-36. PubMed ID: 32000189
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reply to Letter "Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome".
    Senderovich H; Patel P; Jimenez Lopez B; Waicus S
    Med Princ Pract; 2022; 31(5):499-500. PubMed ID: 35817006
    [No Abstract]   [Full Text] [Related]  

  • 72. Cannabis hyperemesis syndrome: Incidence and treatment with topical capsaicin.
    Burillo-Putze G; Trujillo-Burillo D; García-Hernandez JC; López-Hernández MA; Hernández-Ramos I; Ramos-Suárez I; Richards JR
    Med Clin (Barc); 2022 Aug; 159(4):183-186. PubMed ID: 34756408
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cyclical hyperemesis secondary to cannabis abuse].
    Ochoa-Mangado E; Jiménez Giménez M; Salvador Vadillo E; Madoz-Gúrpide A
    Gastroenterol Hepatol; 2009; 32(6):406-9. PubMed ID: 19477551
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
    Kast KA; Gershengoren L
    J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study.
    Pélissier F; Claudet I; Gandia-Mailly P; Benyamina A; Franchitto N
    J Emerg Med; 2016 Nov; 51(5):544-551. PubMed ID: 27485997
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update.
    Perisetti A; Goyal H
    Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):1-8. PubMed ID: 33208685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome.
    Bonnet U
    Med Princ Pract; 2022; 31(5):497-498. PubMed ID: 35817019
    [No Abstract]   [Full Text] [Related]  

  • 78. Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.
    DeVuono MV; Parker LA
    Cannabis Cannabinoid Res; 2020 Jun; 5(2):132-144. PubMed ID: 32656345
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
    Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
    Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus.
    Nana Sede Mbakop R; Kesiena O; Greene TE; Amakye D
    Am J Case Rep; 2023 Feb; 24():e938418. PubMed ID: 36806029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.